Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...

CMS has reached agreements with drug manufacturers to provide gene therapies to treat sickle cell disease to Medicaid recipients under a new outcomes-based model. A total of 33 states, including the ...

Controlling the activity of specific genes in the laboratory through the editing of their epigenetic marks is now a reality ...